| - GRCh37:
- Chr20:31023072
- GRCh38:
- Chr20:32435269
| ASXL1 | P792fs, P853fs | Bohring-Opitz syndrome | Likely pathogenic (Mar 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024769-31024775
- GRCh38:
- Chr20:32436966-32436972
| ASXL1 | K1358fs, K1419fs | Bohring-Opitz syndrome | Pathogenic (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021366-31021369
- GRCh38:
- Chr20:32433563-32433566
| ASXL1 | D396fs, D457fs | Bohring-Opitz syndrome | Pathogenic (Apr 20, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31020776
- GRCh38:
- Chr20:32432973
| ASXL1 | Y297C, Y358C | Bohring-Opitz syndrome | Uncertain significance (Aug 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024021
- GRCh38:
- Chr20:32436218
| ASXL1 | S1108F, S1169F | Bohring-Opitz syndrome | Uncertain significance (Dec 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024665
- GRCh38:
- Chr20:32436862
| ASXL1 | N1323D, N1384D | Bohring-Opitz syndrome | Uncertain significance (May 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024719
- GRCh38:
- Chr20:32436916
| ASXL1 | M1341V, M1402V | Bohring-Opitz syndrome | Uncertain significance (Nov 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024362
- GRCh38:
- Chr20:32436559
| ASXL1 | G1222S, G1283S | Bohring-Opitz syndrome | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31022686
- GRCh38:
- Chr20:32434883
| ASXL1 | L663P, L724P | Bohring-Opitz syndrome | Uncertain significance (Nov 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31023393
- GRCh38:
- Chr20:32435590
| ASXL1 | W960G, W899G | Bohring-Opitz syndrome, Inborn genetic diseases | Uncertain significance (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024561
- GRCh38:
- Chr20:32436758
| ASXL1 | V1288A, V1349A | not provided, Bohring-Opitz syndrome | Uncertain significance (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024651
- GRCh38:
- Chr20:32436848
| ASXL1 | K1318T, K1379T | Bohring-Opitz syndrome | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31022824
- GRCh38:
- Chr20:32435021
| ASXL1 | S709L, S770L | Bohring-Opitz syndrome | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024454-31024469
- GRCh38:
- Chr20:32436651-32436666
| ASXL1 | Q1254fs, Q1315fs | Bohring-Opitz syndrome | Pathogenic (Nov 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021436-31021437
- GRCh38:
- Chr20:32433633-32433634
| ASXL1 | P418fs, P479fs | Bohring-Opitz syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr20:31024080
- GRCh38:
- Chr20:32436277
| ASXL1 | A1128T, A1189T | Bohring-Opitz syndrome | Uncertain significance (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021699
- GRCh38:
- Chr20:32433896
| ASXL1 | E505D, E566D | Bohring-Opitz syndrome | Likely benign (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024192-31024193
- GRCh38:
- Chr20:32436389-32436390
| ASXL1 | L1165fs, L1226fs | Bohring-Opitz syndrome | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31022544
- GRCh38:
- Chr20:32434741
| ASXL1 | P616S, P677S | Bohring-Opitz syndrome | Uncertain significance (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31025138-31025140
- GRCh38:
- Chr20:32437335-32437337
| ASXL1 | | Bohring-Opitz syndrome | Uncertain significance (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31022235
- GRCh38:
- Chr20:32434432
| ASXL1 | I513V, I574V | Bohring-Opitz syndrome | Pathogenic (Aug 16, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr20:31021694
- GRCh38:
- Chr20:32433891
| ASXL1 | E504Q, E565Q | Bohring-Opitz syndrome | Uncertain significance (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021611
- GRCh38:
- Chr20:32433808
| ASXL1 | E476G, E537G | Bohring-Opitz syndrome | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31022838
- GRCh38:
- Chr20:32435035
| ASXL1 | | Bohring-Opitz syndrome | Likely pathogenic (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024430
- GRCh38:
- Chr20:32436627
| ASXL1 | F1244L, F1305L | Bohring-Opitz syndrome | Uncertain significance (Apr 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31023817
- GRCh38:
- Chr20:32436014
| ASXL1 | V1040E, V1101E | Bohring-Opitz syndrome, Myelodysplastic syndrome | Uncertain significance (Jul 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024136
- GRCh38:
- Chr20:32436333
| ASXL1 | | Bohring-Opitz syndrome, Myelodysplastic syndrome, not provided
| Likely benign (Sep 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31022443
- GRCh38:
- Chr20:32434640
| ASXL1 | G582A, G643A | not provided, Bohring-Opitz syndrome | Conflicting interpretations of pathogenicity (Feb 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:31022265-31022266
- GRCh38:
- Chr20:32434462-32434463
| ASXL1 | V524fs, V585fs | Bohring-Opitz syndrome | Likely pathogenic (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31020718
- GRCh38:
- Chr20:32432915
| ASXL1 | Q278*, Q339* | Bohring-Opitz syndrome | Likely pathogenic (Nov 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024858
- GRCh38:
- Chr20:32437055
| ASXL1 | Q1387R, Q1448R | Bohring-Opitz syndrome, not provided | Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31025163
- GRCh38:
- Chr20:32437360
| ASXL1 | | not provided, Bohring-Opitz syndrome | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:30954295
- GRCh38:
- Chr20:32366492
| ASXL1 | | Bohring-Opitz syndrome, not provided | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023750
- GRCh38:
- Chr20:32435947
| ASXL1 | S1018P, S1079P | Inborn genetic diseases, not provided, Bohring-Opitz syndrome
| Benign/Likely benign (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31021521
- GRCh38:
- Chr20:32433718
| ASXL1 | I446N, I507N | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31025231
- GRCh38:
- Chr20:32437428
| ASXL1 | | not provided, Bohring-Opitz syndrome | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024480
- GRCh38:
- Chr20:32436677
| ASXL1 | P1322R, P1261R | not provided, Inborn genetic diseases, Bohring-Opitz syndrome
| Benign/Likely benign (Jul 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023108
- GRCh38:
- Chr20:32435305
| ASXL1 | E804K, E865K | not provided, Inborn genetic diseases, Bohring-Opitz syndrome
| Benign/Likely benign (Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31019024
- GRCh38:
- Chr20:32431221
| ASXL1 | | Bohring-Opitz syndrome, not provided | Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023272-31023273
- GRCh38:
- Chr20:32435469-32435470
| ASXL1 | V861fs, V922fs | Bohring-Opitz syndrome | Pathogenic (Feb 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr20:31022737
- GRCh38:
- Chr20:32434934
| ASXL1 | D680V, D741V | Bohring-Opitz syndrome, not provided | Benign (Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31021721
- GRCh38:
- Chr20:32433918
| ASXL1 | | Bohring-Opitz syndrome | Pathogenic (Feb 17, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr20:30946654
- GRCh38:
- Chr20:32358851
| ASXL1 | | not provided, Bohring-Opitz syndrome, Myelodysplastic syndrome, Bohring-Opitz syndrome | Benign/Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023942
- GRCh38:
- Chr20:32436139
| ASXL1 | S1082R, S1143R | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31021568
- GRCh38:
- Chr20:32433765
| ASXL1 | K462*, K523* | Bohring-Opitz syndrome | Likely pathogenic (Jul 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:30954198
- GRCh38:
- Chr20:32366395
| ASXL1 | Y14fs, Y24fs | Bohring-Opitz syndrome | Likely pathogenic (Dec 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31023952
- GRCh38:
- Chr20:32436149
| ASXL1 | S1085*, S1146* | Bohring-Opitz syndrome | Pathogenic (May 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021590
- GRCh38:
- Chr20:32433787
| ASXL1 | A469V, A530V | Bohring-Opitz syndrome | Uncertain significance (Apr 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021388
- GRCh38:
- Chr20:32433585
| ASXL1 | S463G, S402G | Bohring-Opitz syndrome | Uncertain significance (Jul 24, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024461
- GRCh38:
- Chr20:32436658
| ASXL1 | R1255G, R1316G | Bohring-Opitz syndrome | Uncertain significance (Nov 20, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021226
- GRCh38:
- Chr20:32433423
| ASXL1 | K348E, K409E | Bohring-Opitz syndrome | Uncertain significance (Mar 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31017781
- GRCh38:
- Chr20:32429978
| ASXL1 | A215T | Bohring-Opitz syndrome | Likely pathogenic (May 31, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr20:31017796
- GRCh38:
- Chr20:32429993
| ASXL1 | Q220* | Bohring-Opitz syndrome | Likely pathogenic (May 31, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr20:31023940
- GRCh38:
- Chr20:32436137
| ASXL1 | Q1081R, Q1142R | Bohring-Opitz syndrome | Uncertain significance (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024563
- GRCh38:
- Chr20:32436760
| ASXL1 | Q1289*, Q1350* | Bohring-Opitz syndrome | Pathogenic (Dec 20, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31022234
- GRCh38:
- Chr20:32434431
| ASXL1 | | Bohring-Opitz syndrome | Pathogenic (Jun 24, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31022403-31022425
- GRCh38:
- Chr20:32434600-32434622
| ASXL1 | E635fs, E574fs | not provided, Bohring-Opitz syndrome | Pathogenic/Likely pathogenic (Aug 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31022547-31022548
- GRCh38:
- Chr20:32434744-32434745
| ASXL1 | G619fs, G680fs | Bohring-Opitz syndrome | Pathogenic (Jun 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31023975
- GRCh38:
- Chr20:32436172
| ASXL1 | G1154S, G1093S | Bohring-Opitz syndrome | Uncertain significance (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021426-31021427
- GRCh38:
- Chr20:32433623-32433624
| ASXL1 | E477fs, E416fs | Bohring-Opitz syndrome | Pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31021466
- GRCh38:
- Chr20:32433663
| ASXL1 | R428G, R489G | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024985
- GRCh38:
- Chr20:32437182
| ASXL1 | L1490F, L1429F | Inborn genetic diseases, not provided, Bohring-Opitz syndrome
| Benign/Likely benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024448
- GRCh38:
- Chr20:32436645
| ASXL1 | | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31022413
- GRCh38:
- Chr20:32434610
| ASXL1 | H572R, H633R | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31022438
- GRCh38:
- Chr20:32434635
| ASXL1 | | Bohring-Opitz syndrome, not provided | Benign/Likely benign (Oct 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024055
- GRCh38:
- Chr20:32436252
| ASXL1 | | Bohring-Opitz syndrome, not provided | Benign/Likely benign (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023788
- GRCh38:
- Chr20:32435985
| ASXL1 | | Bohring-Opitz syndrome, not provided | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31021332
- GRCh38:
- Chr20:32433529
| ASXL1 | S383L, S444L | Inborn genetic diseases, not provided, Bohring-Opitz syndrome
| Benign/Likely benign (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31021634
- GRCh38:
- Chr20:32433831
| ASXL1 | R484C, R545C | Bohring-Opitz syndrome, not provided | Benign/Likely benign (Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023899
- GRCh38:
- Chr20:32436096
| ASXL1 | | Bohring-Opitz syndrome, not provided | Benign (Jul 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024254
- GRCh38:
- Chr20:32436451
| ASXL1 | R1186C, R1247C | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31022574
- GRCh38:
- Chr20:32434771
| ASXL1 | C626R, C687R | Bohring-Opitz syndrome, Bohring-Opitz syndrome, Myelodysplastic syndrome, not provided | Benign/Likely benign (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023409-31023411
- GRCh38:
- Chr20:32435606-32435608
| ASXL1 | G906del, G967del | Bohring-Opitz syndrome, not provided | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:31017209
- GRCh38:
- Chr20:32429406
| ASXL1 | | Bohring-Opitz syndrome, not provided | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31022929-31022930
- GRCh38:
- Chr20:32435126-32435127
| ASXL1 | V807fs, V746fs | Bohring-Opitz syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr7:23164330
- GRCh38:
- Chr7:23124711
| KLHL7 | F35fs, F83fs | Bohring-Opitz syndrome | Pathogenic (Apr 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024284
- GRCh38:
- Chr20:32436481
| ASXL1 | A1196fs, A1257fs | Bohring-Opitz syndrome | Likely pathogenic (Jan 1, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024150
- GRCh38:
- Chr20:32436347
| ASXL1 | L1213fs, L1152fs | Bohring-Opitz syndrome | Likely pathogenic (Nov 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024575
- GRCh38:
- Chr20:32436772
| ASXL1 | E1354*, E1293* | Bohring-Opitz syndrome | Pathogenic (Jun 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31022592
- GRCh38:
- Chr20:32434789
| ASXL1 | R693*, R632* | not provided, Bohring-Opitz syndrome, Myelodysplastic syndrome
| Pathogenic/Likely pathogenic (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31021284-31021285
- GRCh38:
- Chr20:32433481-32433482
| ASXL1 | Q428fs, Q367fs | Bohring-Opitz syndrome | Pathogenic (May 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024795-31024797
- GRCh38:
- Chr20:32436992-32436994
| ASXL1 | S1429del, S1368del | Bohring-Opitz syndrome, Myelodysplastic syndrome, not provided
| Uncertain significance (Sep 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024215
- GRCh38:
- Chr20:32436412
| ASXL1 | Q1234*, Q1173* | Bohring-Opitz syndrome | Pathogenic (Sep 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024624-31024626
- GRCh38:
- Chr20:32436821-32436823
| ASXL1 | K1371del, K1310del | Myelodysplastic syndrome, not provided, Bohring-Opitz syndrome
| Uncertain significance (May 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024636-31024637
- GRCh38:
- Chr20:32436833-32436834
| ASXL1 | P1377fs, P1316fs | not provided, Inborn genetic diseases, Myelodysplastic syndrome, Bohring-Opitz syndrome | Pathogenic/Likely pathogenic (May 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:30956891
- GRCh38:
- Chr20:32369088
| ASXL1 | K73*, K63* | Bohring-Opitz syndrome | Pathogenic (Dec 11, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024265-31024269
- GRCh38:
- Chr20:32436462-32436466
| ASXL1 | | Bohring-Opitz syndrome | Pathogenic (Jun 20, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr20:31023717
- GRCh38:
- Chr20:32435914
| ASXL1 | R1068*, R1007* | not provided, Bohring-Opitz syndrome | Pathogenic (Nov 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31022441-31022442
- GRCh38:
- Chr20:32434638-32434639
| ASXL1 | G585fs, G646fs | Bohring-Opitz syndrome, Abnormality of brain morphology, not provided
| Pathogenic/Likely pathogenic (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31026697-31026698
- GRCh38:
- Chr20:32438894-32438895
| ASXL1 | | Bohring-Opitz syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr20:31024613
- GRCh38:
- Chr20:32436810
| ASXL1 | | not provided, Bohring-Opitz syndrome | Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024274
- GRCh38:
- Chr20:32436471
| ASXL1 | | not specified, not provided, Bohring-Opitz syndrome
| Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31024028
- GRCh38:
- Chr20:32436225
| ASXL1 | | not provided, Bohring-Opitz syndrome | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023866
- GRCh38:
- Chr20:32436063
| ASXL1 | | not provided, Bohring-Opitz syndrome | Conflicting interpretations of pathogenicity (Sep 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:31023727
- GRCh38:
- Chr20:32435924
| ASXL1 | A1071V, A1010V | not provided, Bohring-Opitz syndrome | Conflicting interpretations of pathogenicity (Jun 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:31023544
- GRCh38:
- Chr20:32435741
| ASXL1 | T1010M, T949M | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023500
- GRCh38:
- Chr20:32435697
| ASXL1 | | not provided, Bohring-Opitz syndrome | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023317
- GRCh38:
- Chr20:32435514
| ASXL1 | | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023059
- GRCh38:
- Chr20:32435256
| ASXL1 | | not provided, Bohring-Opitz syndrome | Likely benign (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:31023041
- GRCh38:
- Chr20:32435238
| ASXL1 | | not provided, Bohring-Opitz syndrome | Benign/Likely benign (Sep 28, 2022) | criteria provided, multiple submitters, no conflicts |